RE:RE:Change?The documentation requirements for the FDA may be 20-30 thousand pages. Lets just assume I was told that. Much of that documentation is independent of the success of the cell line and safety. Of course those two items you mentioned are key pieces of the total documentation. Beginning to identify what documentation is necessary and beginning to pull it together is what the Company should be doing over the next 6-9 months. That is a huge project. Fair enough? The Company is becoming Massachusetts based, wouldn't the FDA be the likely choice of the US based Boston Group and their 40%+ ownership? I am hoping the Company will do a live conference call for Q3 with written questions from shareholders. I have been advocating for that, so that shareholders can get their questions answered and hear directly from the Company.